36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel).

Details

Request a copyRequest a copy
Serval ID
serval:BIB_002755517A9D
Type
Inproceedings: an article in a conference proceedings.
Collection
Publications
Institution
Production externe
Title
36-months follow-up of the Phase 1 clinical trial of the use ciliary neurotrophic factor (CNTF) for Macular Telangiectasia Type 2 (MacTel).
Title of the conference
ARVO Annual Meeting 2015, Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1815.
Author(s)
Peto Tunde, Clemons Traci E., Chew Emily Y., Leung Irene, Sallo Ferenc B., Bird Alan C.
Working group(s)
MacTel Study Group
Publication state
Published
Issued date
03/05/2015
Peer-reviewed
Oui
Language
english
Create date
29/09/2024 21:27
Last modification date
30/09/2024 7:05
Usage data